Single- and Multiple-Dose Pharmacokinetics and Pharmacodynamics of PN-943, a Gastrointestinal-Restricted Oral Peptide Antagonist of α4β7, in Healthy Volunteers.
Saved in:
| Title: | Single- and Multiple-Dose Pharmacokinetics and Pharmacodynamics of PN-943, a Gastrointestinal-Restricted Oral Peptide Antagonist of α4β7, in Healthy Volunteers. |
|---|---|
| Authors: | Modi NB; Protagonist Therapeutics, Inc, Newark, California, USA., Cheng X; Protagonist Therapeutics, Inc, Newark, California, USA., Mattheakis L; Protagonist Therapeutics, Inc, Newark, California, USA., Hwang CC; Protagonist Therapeutics, Inc, Newark, California, USA., Nawabi R; Protagonist Therapeutics, Inc, Newark, California, USA., Liu D; Protagonist Therapeutics, Inc, Newark, California, USA., Gupta S; Protagonist Therapeutics, Inc, Newark, California, USA. |
| Source: | Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2021 Nov; Vol. 10 (11), pp. 1263-1278. Date of Electronic Publication: 2021 May 04. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2160-7648 (Electronic) Linking ISSN: 2160763X NLM ISO Abbreviation: Clin Pharmacol Drug Dev Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2160-7648 |
|---|---|
| DOI: | 10.1002/cpdd.946 |
